HomeGermanyEarlybird Health Closes Fund, at €173M

Earlybird Health Closes Fund, at €173M

Earlybird Health

Earlybird Health, a Berlin, and Cologne, Germany-based venture capital firm focused on healthcare innovations that improve patient outcomes, closed its latest healthcare fund, at €173M.

The fund received support from health insurers and strategic investors to public and private organisations across the entire region.

Earlybird Health Fund will invest in European companies from the early development stage to advanced technologies nearing regulatory approval and commercialisation. The vehicle aims to invest in companies across healthcare sectors including digital health, diagnostics, medical devices, R&D tools, and biopharma – delivering positive patient outcomes, regardless of the technology applied. With a team of more than 10 professionals, Earlybird Health brings investment expertise and provide financial and strategic support to its portfolio companies.

To augment investment team experience, Earlybird uses a proprietary in-house technology, Eagle Eye, for deal sourcing. Harnessing data aggregation and curation of multiple sources, this AI tool scouts new startups and gathers information for established entities. The tool increases deal flow from stealth mode companies to crossover financing rounds, offering market intelligence through competitor analyses and trend reports.

The fund also complies with the Article 8 Fund criteria, per the EU’s Sustainable Finance Disclosure Regulation (SFDR).

Founded in 1997, Earlybird Venture Capital invests out of a family of independently managed funds, including flagship funds Digital West (Western Europe), Digital East (Emerging Europe), and Health. With EUR 2 billion under management across all fund streams, 9 IPOs, and 32 trade sales, Earlybird is one of Europe’s most established and active venture capital firms.